Frontier Capital Management CO LLC Fibrogen Inc Transaction History
Frontier Capital Management CO LLC
- $10.2 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding FGEN
# of Institutions
120Shares Held
62.2MCall Options Held
1.54MPut Options Held
221K-
Primecap Management CO Pasadena, CA14.4MShares$12.8 Million0.03% of portfolio
-
Armistice Capital, LLC New York, NY7.94MShares$7.06 Million0.25% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$6.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.44MShares$5.73 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.5MShares$2.23 Million0.02% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $83.4M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...